(1) After consultation with the AIDS Research Advisory Committee established pursuant to section
300cc–3 of this title, the Secretary shall establish a program for the evaluation of drugs that
(A) are not approved by the Commissioner of Food and Drugs for the purpose of treatments with respect to acquired immune deficiency syndrome; and
(B) are being utilized for such purpose by individuals infected with the etiologic agent for such syndrome.